speb/financial-data huggingface dataset:
DML.TO balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 114810000.00
DML.TO balance_sheet (annual, 2024-12-31) — Cash Equivalents: 104436000.00
DML.TO balance_sheet (annual, 2024-12-31) — Cash Financial: 4082000.00
DML.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 15154000.00
DML.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 426000.00
DML.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -40384000.00
DML.TO cash_flow (annual, 2024-12-31) — Change In Inventory: -165000.00
DML.TO cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 9181000.00
DML.TO cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -524000.00
DML.TO cash_flow (annual, 2024-12-31) — Change In Receivables: -823000.00
DML.TO cash_flow (annual, 2024-12-31) — Change In Working Capital: 7669000.00
DML.TO cash_flow (annual, 2024-12-31) — Changes In Cash: -24804000.00
DML.TO balance_sheet (annual, 2024-12-31) — Common Stock: 1665189000.00
DML.TO balance_sheet (annual, 2024-12-31) — Common Stock Equity: 564322000.00
DML.TO cash_flow (annual, 2024-12-31) — Common Stock Issuance: 14082000.00
DML.TO cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 14082000.00
DML.TO income_statement (annual, 2024-12-31) — Cost Of Revenue: 4815000.00
DML.TO income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 1198000.00
DML.TO balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 0.00
DML.TO balance_sheet (quarterly, 2024-12-31) — Current Accrued Expenses: 0.00
DML.TO balance_sheet (annual, 2024-12-31) — Current Assets: 123724000.00
DML.TO balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 4501000.00
DML.TO balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 4501000.00
DML.TO balance_sheet (annual, 2024-12-31) — Current Liabilities: 33891000.00
DML.TO balance_sheet (annual, 2024-12-31) — Current Provisions: 1713000.00
DML.TO cash_flow (annual, 2024-12-31) — Deferred Income Tax: -236000.00
DML.TO cash_flow (annual, 2024-12-31) — Deferred Tax: -236000.00
DML.TO cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 9929000.00
DML.TO balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 0.00
DML.TO balance_sheet (quarterly, 2024-12-31) — Derivative Product Liabilities: 0.00
DML.TO income_statement (annual, 2024-12-31) — Diluted Average Shares: 892238000.00
DML.TO income_statement (annual, 2024-12-31) — Diluted EPS: -0.10
DML.TO income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -91119000.00
DML.TO balance_sheet (annual, 2024-12-31) — Dueto Related Parties Current: 7007000.00
DML.TO income_statement (annual, 2024-12-31) — EBIT: -91718000.00
DML.TO income_statement (annual, 2024-12-31) — EBITDA: -81789000.00
DML.TO income_statement (annual, 2024-12-31) — Earnings From Equity Interest: 16000.00
DML.TO cash_flow (annual, 2024-12-31) — Earnings Losses From Equity Investments: -16000.00
DML.TO cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 2268000.00
DML.TO cash_flow (annual, 2024-12-31) — End Cash Position: 108518000.00
DML.TO balance_sheet (annual, 2024-12-31) — Financial Assets: 0.00
DML.TO balance_sheet (quarterly, 2024-12-31) — Financial Assets: 0.00
DML.TO cash_flow (annual, 2024-12-31) — Financing Cash Flow: 15154000.00
DML.TO cash_flow (annual, 2024-12-31) — Free Cash Flow: -48074000.00
DML.TO cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: -162000.00
DML.TO cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of PPE: -13000.00
DML.TO income_statement (annual, 2024-12-31) — Gain On Sale Of Ppe: 162000.00
DML.TO income_statement (quarterly, 2024-12-31) — Gain On Sale Of Ppe: 142000.00
DML.TO income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -37350000.00
DML.TO balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 1822000.00
DML.TO income_statement (annual, 2024-12-31) — General And Administrative Expense: 16495000.00
DML.TO balance_sheet (annual, 2024-12-31) — Gross PPE: 302725000.00
DML.TO income_statement (annual, 2024-12-31) — Gross Profit: -792000.00
DML.TO income_statement (quarterly, 2024-12-31) — Gross Profit: -28000.00
DML.TO balance_sheet (annual, 2024-12-31) — Held To Maturity Securities: 13000000.00
DML.TO income_statement (annual, 2024-12-31) — Interest Expense: 108000.00
DML.TO income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 108000.00
DML.TO income_statement (annual, 2024-12-31) — Interest Income: 7719000.00
DML.TO income_statement (annual, 2024-12-31) — Interest Income Non Operating: 7719000.00
DML.TO cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 5000.00
DML.TO balance_sheet (annual, 2024-12-31) — Interest Payable: 0.00
DML.TO balance_sheet (quarterly, 2024-12-31) — Interest Payable: 0.00
DML.TO balance_sheet (annual, 2024-12-31) — Inventory: 3746000.00
DML.TO balance_sheet (annual, 2024-12-31) — Invested Capital: 564322000.00
DML.TO cash_flow (annual, 2024-12-31) — Investing Cash Flow: 426000.00
DML.TO balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 14755000.00
DML.TO balance_sheet (annual, 2024-12-31) — Investments And Advances: 266506000.00
DML.TO balance_sheet (annual, 2024-12-31) — Investmentsin Joint Venturesat Cost: 20663000.00
DML.TO cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 14082000.00
DML.TO cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 14082000.00
DML.TO cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
DML.TO cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 0.00
DML.TO cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -301000.00
DML.TO balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 20663000.00
DML.TO balance_sheet (annual, 2024-12-31) — Long Term Provisions: 30601000.00
DML.TO balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 118567000.00
DML.TO cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: -5329000.00
DML.TO cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 14082000.00
DML.TO cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 14082000.00
DML.TO cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: -2278000.00
DML.TO income_statement (annual, 2024-12-31) — Net Income: -91119000.00
DML.TO income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -91119000.00
DML.TO income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -91590000.00
DML.TO income_statement (annual, 2024-12-31) — Net Income Discontinuous Operations: 471000.00
DML.TO income_statement (quarterly, 2024-12-31) — Net Income Discontinuous Operations: 0.00
DML.TO income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -91119000.00
DML.TO income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -91590000.00
DML.TO cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -91119000.00
DML.TO income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -91119000.00
DML.TO income_statement (annual, 2024-12-31) — Net Interest Income: 4553000.00
DML.TO cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 13598000.00
DML.TO cash_flow (quarterly, 2024-12-31) — Net Investment Purchase And Sale: 0.00
DML.TO cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -301000.00
DML.TO cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -301000.00
DML.TO income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 4553000.00
DML.TO cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -393000.00
DML.TO balance_sheet (annual, 2024-12-31) — Net PPE: 259661000.00
DML.TO cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -7450000.00
DML.TO balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 564322000.00
DML.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 31863000.00
DML.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 29492000.00
DML.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 2371000.00
DML.TO income_statement (annual, 2024-12-31) — Normalized EBITDA: -44601000.00
DML.TO income_statement (annual, 2024-12-31) — Normalized Income: -54497576.07
DML.TO cash_flow (annual, 2024-12-31) — Operating Cash Flow: -40384000.00
DML.TO cash_flow (annual, 2024-12-31) — Operating Gains Losses: -2456000.00
DML.TO income_statement (annual, 2024-12-31) — Operating Income: -63323000.00
DML.TO income_statement (annual, 2024-12-31) — Operating Revenue: 4023000.00
DML.TO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 895713101.00
DML.TO balance_sheet (annual, 2024-12-31) — Other Current Assets: 2093000.00
DML.TO balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 6344000.00
DML.TO balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 1822000.00
DML.TO income_statement (annual, 2024-12-31) — Other Gand A: 16495000.00
DML.TO income_statement (annual, 2024-12-31) — Other Income Expense: -33056000.00
DML.TO balance_sheet (annual, 2024-12-31) — Other Investments: 231088000.00
DML.TO cash_flow (annual, 2024-12-31) — Other Non Cash Items: -8456000.00
DML.TO balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 13722000.00
DML.TO balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 2936000.00
DML.TO income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 4116000.00
DML.TO income_statement (annual, 2024-12-31) — Other Operating Expenses: 50851000.00
DML.TO balance_sheet (annual, 2024-12-31) — Other Payable: 1037000.00
DML.TO balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 6292000.00
DML.TO balance_sheet (annual, 2024-12-31) — Payables: 21333000.00
DML.TO balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 21333000.00
DML.TO income_statement (annual, 2024-12-31) — Pretax Income: -91826000.00
DML.TO cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 1373000.00
DML.TO cash_flow (annual, 2024-12-31) — Purchase Of Business: -5329000.00
DML.TO cash_flow (annual, 2024-12-31) — Purchase Of Investment: 0.00
DML.TO cash_flow (annual, 2024-12-31) — Purchase Of PPE: -7690000.00
DML.TO balance_sheet (annual, 2024-12-31) — Raw Materials: 3746000.00
DML.TO balance_sheet (quarterly, 2024-12-31) — Raw Materials: 3746000.00
DML.TO balance_sheet (annual, 2024-12-31) — Receivables: 3075000.00
DML.TO income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 4815000.00
DML.TO income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 1198000.00
DML.TO income_statement (annual, 2024-12-31) — Reconciled Depreciation: 9929000.00
DML.TO cash_flow (annual, 2024-12-31) — Repayment Of Debt: -301000.00
DML.TO balance_sheet (annual, 2024-12-31) — Retained Earnings: -1176000000.00
DML.TO cash_flow (annual, 2024-12-31) — Sale Of Investment: 13598000.00
DML.TO cash_flow (quarterly, 2024-12-31) — Sale Of Investment: 0.00
DML.TO cash_flow (annual, 2024-12-31) — Sale Of PPE: 240000.00
DML.TO cash_flow (quarterly, 2024-12-31) — Sale Of PPE: 13000.00
DML.TO income_statement (annual, 2024-12-31) — Selling General And Administration: 16495000.00
DML.TO balance_sheet (annual, 2024-12-31) — Share Issued: 895713101.00
DML.TO income_statement (annual, 2024-12-31) — Special Income Charges: 162000.00
DML.TO income_statement (quarterly, 2024-12-31) — Special Income Charges: 142000.00
DML.TO cash_flow (annual, 2024-12-31) — Stock Based Compensation: 4657000.00
DML.TO balance_sheet (annual, 2024-12-31) — Stockholders Equity: 564322000.00
DML.TO balance_sheet (annual, 2024-12-31) — Tangible Book Value: 564322000.00
DML.TO income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -95576.07
DML.TO income_statement (annual, 2024-12-31) — Tax Provision: -236000.00
DML.TO income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
DML.TO balance_sheet (annual, 2024-12-31) — Total Assets: 663613000.00
DML.TO balance_sheet (annual, 2024-12-31) — Total Capitalization: 564322000.00
DML.TO balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 564322000.00
DML.TO income_statement (annual, 2024-12-31) — Total Expenses: 67346000.00
DML.TO balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 99291000.00
DML.TO balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 539889000.00
DML.TO balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 65400000.00
DML.TO income_statement (annual, 2024-12-31) — Total Other Finance Cost: 3058000.00
DML.TO income_statement (quarterly, 2024-12-31) — Total Other Finance Cost: 692000.00
DML.TO income_statement (annual, 2024-12-31) — Total Unusual Items: -37188000.00
DML.TO income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -37188000.00
DML.TO cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 39628000.00
DML.TO balance_sheet (annual, 2024-12-31) — Working Capital: 89833000.00
DML.TO income_statement (quarterly, 2025-03-31) — +Operating Expense: 23511000.00
DML.TO income_statement (quarterly, 2025-03-31) — +Total Revenue: 1375000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 15864000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 3802000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -44439000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 73921000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 5172000.00
DML.TO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 895775000.00
DML.TO income_statement (quarterly, 2025-03-31) — Basic EPS: -0.05
DML.TO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 108518000.00
DML.TO cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -6087000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 1665995000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 83576000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 90665000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 80011000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Cash Financial: 3565000.00
DML.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -331000.00
DML.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -7715000.00
DML.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -16876000.00
DML.TO cash_flow (quarterly, 2025-03-31) — Change In Inventory: -23000.00
DML.TO cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 3071000.00
DML.TO cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 23000.00
DML.TO cash_flow (quarterly, 2025-03-31) — Change In Receivables: -834000.00
DML.TO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 2237000.00
DML.TO cash_flow (quarterly, 2025-03-31) — Changes In Cash: -24922000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Common Stock: 1665995000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 522202000.00
DML.TO income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 0.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Current Assets: 100762000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 4517000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 4517000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 31386000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Current Provisions: 1622000.00
DML.TO cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -6024000.00
DML.TO cash_flow (quarterly, 2025-03-31) — Deferred Tax: -6024000.00
DML.TO cash_flow (quarterly, 2025-03-31) — Depletion: 2508000.00
DML.TO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 2508000.00
DML.TO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 895775000.00
DML.TO income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.05
DML.TO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -43534000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Dueto Related Parties Current: 7268000.00
DML.TO income_statement (quarterly, 2025-03-31) — EBIT: -48878000.00
DML.TO income_statement (quarterly, 2025-03-31) — EBITDA: -46370000.00
DML.TO income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: -902000.00
DML.TO cash_flow (quarterly, 2025-03-31) — Earnings Losses From Equity Investments: 511000.00
DML.TO cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -20000.00
DML.TO cash_flow (quarterly, 2025-03-31) — End Cash Position: 83576000.00
DML.TO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -331000.00
DML.TO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -22963000.00
DML.TO cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of Business: 140000.00
DML.TO cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: 0.00
DML.TO income_statement (quarterly, 2025-03-31) — Gain On Sale Of Business: 251000.00
DML.TO income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -27563000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 1820000.00
DML.TO income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 4743000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Gross PPE: 305012000.00
DML.TO income_statement (quarterly, 2025-03-31) — Gross Profit: 1375000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Held To Maturity Securities: 12222000.00
DML.TO income_statement (quarterly, 2025-03-31) — Interest Expense: 680000.00
DML.TO income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 680000.00
DML.TO income_statement (quarterly, 2025-03-31) — Interest Income: 1316000.00
DML.TO income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 1316000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Inventory: 3769000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 522202000.00
DML.TO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -7715000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 17394000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 241385000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Investmentsin Joint Venturesat Cost: 20152000.00
DML.TO cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -108000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 20152000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 30873000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 124059000.00
DML.TO cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: -632000.00
DML.TO cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 17000.00
DML.TO income_statement (quarterly, 2025-03-31) — Net Income: -43534000.00
DML.TO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -43534000.00
DML.TO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -43534000.00
DML.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -43534000.00
DML.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -43534000.00
DML.TO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -43534000.00
DML.TO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -43534000.00
DML.TO income_statement (quarterly, 2025-03-31) — Net Interest Income: 636000.00
DML.TO cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -108000.00
DML.TO cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -108000.00
DML.TO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 636000.00
DML.TO cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -252000.00
DML.TO cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -996000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Net PPE: 260573000.00
DML.TO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -6087000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 522202000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 30976000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 28779000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 2197000.00
DML.TO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -18807000.00
DML.TO income_statement (quarterly, 2025-03-31) — Normalized Income: -19321407.85
DML.TO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -16876000.00
DML.TO cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 528000.00
DML.TO income_statement (quarterly, 2025-03-31) — Operating Income: -22136000.00
DML.TO income_statement (quarterly, 2025-03-31) — Operating Revenue: 1375000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 896207766.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 2526000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 484000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 1820000.00
DML.TO income_statement (quarterly, 2025-03-31) — Other Gand A: 4743000.00
DML.TO income_statement (quarterly, 2025-03-31) — Other Income Expense: -28058000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Other Investments: 203839000.00
DML.TO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -1664000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 15664000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 2947000.00
DML.TO income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 407000.00
DML.TO income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 18768000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Other Payable: 1631000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 7089000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Payables: 24763000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 24763000.00
DML.TO income_statement (quarterly, 2025-03-31) — Pretax Income: -49558000.00
DML.TO cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 29000.00
DML.TO cash_flow (quarterly, 2025-03-31) — Purchase Of Business: -632000.00
DML.TO cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -6087000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Receivables: 3802000.00
DML.TO income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 0.00
DML.TO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 2508000.00
DML.TO cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -108000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -1219534000.00
DML.TO cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 0.00
DML.TO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 4743000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Share Issued: 896207766.00
DML.TO income_statement (quarterly, 2025-03-31) — Special Income Charges: 251000.00
DML.TO cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 1387000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 522202000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 522202000.00
DML.TO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -3350407.85
DML.TO income_statement (quarterly, 2025-03-31) — Tax Provision: -6024000.00
DML.TO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.12
DML.TO balance_sheet (quarterly, 2025-03-31) — Total Assets: 618384000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 522202000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 522202000.00
DML.TO income_statement (quarterly, 2025-03-31) — Total Expenses: 23511000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 96182000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 517622000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 64796000.00
DML.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items: -27563000.00
DML.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -27563000.00
DML.TO cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: 27686000.00
DML.TO balance_sheet (quarterly, 2025-03-31) — Working Capital: 69376000.00
DML.TO income_statement (quarterly, 2025-06-30) — +Operating Expense: 20066000.00
DML.TO income_statement (quarterly, 2025-06-30) — +Total Revenue: 1276000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 9934000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 4115000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -45890000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 74785000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 5075000.00
DML.TO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 896322000.00
DML.TO income_statement (quarterly, 2025-06-30) — Basic EPS: 0.01
DML.TO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 83576000.00
DML.TO cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -5232000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 1666474000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 54533000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 94224000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Cash Equivalents: 49736000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Cash Financial: 4797000.00
DML.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 2000.00
DML.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -4757000.00
DML.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -22968000.00
DML.TO cash_flow (quarterly, 2025-06-30) — Change In Inventory: -333000.00
DML.TO cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -5569000.00
DML.TO cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -451000.00
DML.TO cash_flow (quarterly, 2025-06-30) — Change In Receivables: -429000.00
DML.TO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -6782000.00
DML.TO cash_flow (quarterly, 2025-06-30) — Changes In Cash: -27723000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Common Stock: 1666474000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 535855000.00
DML.TO income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 1386000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Current Assets: 105425000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 4517000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 4517000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 26726000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Current Provisions: 1569000.00
DML.TO cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -83000.00
DML.TO cash_flow (quarterly, 2025-06-30) — Deferred Tax: -83000.00
DML.TO cash_flow (quarterly, 2025-06-30) — Depletion: 2724000.00
DML.TO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 2724000.00
DML.TO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 903172000.00
DML.TO income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.01
DML.TO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 12498000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Dueto Related Parties Current: 8236000.00
DML.TO income_statement (quarterly, 2025-06-30) — EBIT: 12469000.00
DML.TO income_statement (quarterly, 2025-06-30) — EBITDA: 15193000.00
DML.TO income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest: -1785000.00
DML.TO cash_flow (quarterly, 2025-06-30) — Earnings Losses From Equity Investments: 426000.00
DML.TO cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -1320000.00
DML.TO cash_flow (quarterly, 2025-06-30) — End Cash Position: 54533000.00
DML.TO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 2000.00
DML.TO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -28200000.00
DML.TO cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: 0.00
DML.TO income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 32380000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 1632000.00
DML.TO income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 4603000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Gross PPE: 311309000.00
DML.TO income_statement (quarterly, 2025-06-30) — Gross Profit: -110000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Held To Maturity Securities: 12492000.00
DML.TO income_statement (quarterly, 2025-06-30) — Interest Expense: 54000.00
DML.TO income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 54000.00
DML.TO income_statement (quarterly, 2025-06-30) — Interest Income: 941000.00
DML.TO income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 941000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Inventory: 4102000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 535855000.00
DML.TO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -4757000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 17567000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 240780000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Investmentsin Joint Venturesat Cost: 19726000.00
DML.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -134000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 19726000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 31145000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 126765000.00
DML.TO cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: 0.00
DML.TO cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: 1110000.00
DML.TO income_statement (quarterly, 2025-06-30) — Net Income: 12498000.00
DML.TO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 12498000.00
DML.TO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 12498000.00
DML.TO income_statement (quarterly, 2025-06-30) — Net Income Discontinuous Operations: 0.00
DML.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 12498000.00
DML.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 12498000.00
DML.TO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 12498000.00
DML.TO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 12498000.00
DML.TO income_statement (quarterly, 2025-06-30) — Net Interest Income: 168000.00
DML.TO cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -134000.00
DML.TO cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -134000.00
DML.TO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 168000.00
DML.TO cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 0.00
DML.TO cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 475000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Net PPE: 265419000.00
DML.TO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -5232000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 535855000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 30336000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 28222000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 2114000.00
DML.TO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -17187000.00
DML.TO income_statement (quarterly, 2025-06-30) — Normalized Income: -15025000.00
DML.TO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -22968000.00
DML.TO cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 1536000.00
DML.TO income_statement (quarterly, 2025-06-30) — Operating Income: -18790000.00
DML.TO income_statement (quarterly, 2025-06-30) — Operating Revenue: 1276000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 896422542.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 2984000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 567000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 1632000.00
DML.TO income_statement (quarterly, 2025-06-30) — Other Gand A: 4603000.00
DML.TO income_statement (quarterly, 2025-06-30) — Other Income Expense: 31037000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Other Investments: 203487000.00
DML.TO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -1653000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 15259000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 2821000.00
DML.TO income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 442000.00
DML.TO income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 15463000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Other Payable: 1903000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Other Properties: 2184000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 39691000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Payables: 20073000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 20073000.00
DML.TO income_statement (quarterly, 2025-06-30) — Pretax Income: 12415000.00
DML.TO cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 136000.00
DML.TO cash_flow (quarterly, 2025-06-30) — Purchase Of Business: 0.00
DML.TO cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -5232000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Receivables: 4115000.00
DML.TO income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 1386000.00
DML.TO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 2724000.00
DML.TO cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -134000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -1207036000.00
DML.TO cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 0.00
DML.TO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 4603000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Share Issued: 896422542.00
DML.TO cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 1099000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 535855000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 535855000.00
DML.TO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 4857000.00
DML.TO income_statement (quarterly, 2025-06-30) — Tax Provision: -83000.00
DML.TO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.15
DML.TO balance_sheet (quarterly, 2025-06-30) — Total Assets: 626883000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 535855000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 535855000.00
DML.TO income_statement (quarterly, 2025-06-30) — Total Expenses: 20066000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 91028000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 521458000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 64302000.00
DML.TO income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: 719000.00
DML.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items: 32380000.00
DML.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 32380000.00
DML.TO cash_flow (quarterly, 2025-06-30) — Unrealized Gain Loss On Investment Securities: -32307000.00
DML.TO balance_sheet (quarterly, 2025-06-30) — Working Capital: 78699000.00
DML.TO income_statement (quarterly, 2025-09-30) — +Operating Expense: 23148000.00
DML.TO income_statement (quarterly, 2025-09-30) — +Total Revenue: 1045000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 23576000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 7177000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -48633000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 75214000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 5890000.00
DML.TO income_statement (quarterly, 2025-09-30) — Basic Average Shares: 896574000.00
DML.TO income_statement (quarterly, 2025-09-30) — Basic EPS: -0.15
DML.TO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 54533000.00
DML.TO cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -7773000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 1667975000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 471258000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 482802000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Cash Equivalents: 466416000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Cash Financial: 4842000.00
DML.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 459864000.00
DML.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -26306000.00
DML.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -19870000.00
DML.TO cash_flow (quarterly, 2025-09-30) — Change In Inventory: -2908000.00
DML.TO cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 5064000.00
DML.TO cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 1028000.00
DML.TO cash_flow (quarterly, 2025-09-30) — Change In Receivables: -3171000.00
DML.TO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 13000.00
DML.TO cash_flow (quarterly, 2025-09-30) — Changes In Cash: 413688000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Common Stock: 1667975000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 402902000.00
DML.TO income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 1209000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 2535000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Current Assets: 499904000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 4517000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 4517000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 41753000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Current Provisions: 1135000.00
DML.TO cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: -421000.00
DML.TO cash_flow (quarterly, 2025-09-30) — Deferred Tax: -421000.00
DML.TO cash_flow (quarterly, 2025-09-30) — Depletion: 5492000.00
DML.TO cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 5492000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Derivative Product Liabilities: 303685000.00
DML.TO income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 896574000.00
DML.TO income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.15
DML.TO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -134965000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Dueto Related Parties Current: 8341000.00
DML.TO income_statement (quarterly, 2025-09-30) — EBIT: -130375000.00
DML.TO income_statement (quarterly, 2025-09-30) — EBITDA: -124883000.00
DML.TO income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest: -367000.00
DML.TO cash_flow (quarterly, 2025-09-30) — Earnings Losses From Equity Investments: 243000.00
DML.TO cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 3037000.00
DML.TO cash_flow (quarterly, 2025-09-30) — End Cash Position: 471258000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Financial Assets: 56731000.00
DML.TO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 459864000.00
DML.TO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -27643000.00
DML.TO cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: 0.00
DML.TO income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -109887000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 1714000.00
DML.TO income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 3664000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Gross PPE: 329220000.00
DML.TO income_statement (quarterly, 2025-09-30) — Gross Profit: -164000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Held To Maturity Securities: 12589000.00
DML.TO income_statement (quarterly, 2025-09-30) — Interest Expense: 5011000.00
DML.TO income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 5011000.00
DML.TO income_statement (quarterly, 2025-09-30) — Interest Income: 2788000.00
DML.TO income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 2788000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Interest Payable: 2535000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Inventory: 7962000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 697730000.00
DML.TO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -26306000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 18479000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 254863000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Investmentsin Joint Venturesat Cost: 19483000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 294828000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 294828000.00
DML.TO cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -117000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 19483000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 31735000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 143957000.00
DML.TO cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: -1066000.00
DML.TO cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: -530000.00
DML.TO income_statement (quarterly, 2025-09-30) — Net Income: -134965000.00
DML.TO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -134965000.00
DML.TO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -134965000.00
DML.TO income_statement (quarterly, 2025-09-30) — Net Income Discontinuous Operations: 0.00
DML.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -134965000.00
DML.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -134965000.00
DML.TO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -134965000.00
DML.TO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -134965000.00
DML.TO income_statement (quarterly, 2025-09-30) — Net Interest Income: -2995000.00
DML.TO cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -17656000.00
DML.TO cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 458877000.00
DML.TO cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 458877000.00
DML.TO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -2995000.00
DML.TO cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 0.00
DML.TO cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 189000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Net PPE: 280587000.00
DML.TO cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -7773000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 402902000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 29589000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 27896000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 1693000.00
DML.TO income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -14996000.00
DML.TO income_statement (quarterly, 2025-09-30) — Normalized Income: -25419707.61
DML.TO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -19870000.00
DML.TO cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 90403000.00
DML.TO income_statement (quarterly, 2025-09-30) — Operating Income: -22103000.00
DML.TO income_statement (quarterly, 2025-09-30) — Operating Revenue: 1045000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 897186541.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 1963000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 630000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 1714000.00
DML.TO income_statement (quarterly, 2025-09-30) — Other Gand A: 3664000.00
DML.TO income_statement (quarterly, 2025-09-30) — Other Income Expense: -110288000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Other Investments: 216901000.00
DML.TO cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 34647000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 15090000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 2683000.00
DML.TO income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -34000.00
DML.TO income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 19484000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Other Payable: 1019000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Other Properties: 2184000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 11544000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Payables: 32936000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 35471000.00
DML.TO income_statement (quarterly, 2025-09-30) — Pretax Income: -135386000.00
DML.TO cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 987000.00
DML.TO cash_flow (quarterly, 2025-09-30) — Purchase Of Business: -1066000.00
DML.TO cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -7773000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Raw Materials: 7962000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Receivables: 7177000.00
DML.TO income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 1209000.00
DML.TO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 5492000.00
DML.TO cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -117000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -1342001000.00
DML.TO cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 31166000.00
DML.TO cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 0.00
DML.TO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 3664000.00
DML.TO balance_sheet (quarterly, 2025-09-30) — Share Issued: 897186541.00